Purple Biotech Ltd (PPBT)Healthcare | Biotechnology | Rehovot, Israel | NasdaqCM
1.68 USD
+0.02
(1.205%)
⇧
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 1.68 |
Hot Take ↕ | Aug. 22, 2026, 3:26 a.m. EDT
This biotech stock represents a catastrophic failure of capital preservation, making it unsuitable for any investment horizon. The fundamental reality is stark: the company has endured nine consecutive years of declining annual returns, erasing over 99% of its value since 2016. Despite a 'strong buy' analyst recommendation and a theoretical target price of $17, these metrics are irrelevant given the negative earnings, massive cash burn, and a balance sheet that cannot sustain operations without further dilution. The price action confirms this structural implosion, trading near its 52-week low with no recovery in sight. With zero dividend history and no credible path to profitability visible in the data, the only rational stance is avoidance. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.074227 |
| AutoETS | 0.074235 |
| MSTL | 0.094068 |
| AutoTheta | 0.310627 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 34% |
| H-stat | 0.40 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.186 |
| Excess Kurtosis | -1.28 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 1.097 |
| Market Cap | 2,733,136 |
| Forward P/E | -1.66 |
| Beta | -0.54 |
| Previous Name | Kitov Pharma Ltd |
| Website | https://purple-biotech.com |
As of Aug. 22, 2026, 3:26 a.m. EDT: Speculator positioning is virtually non-existent, with negligible open interest and volume across both calls and puts. The sparse data suggests a lack of active directional bets, reflecting the security's obscurity and low liquidity rather than a specific contrarian thesis.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.8830986 |
| Address1 | 4 Oppenheimer Street |
| Address2 | Science Park |
| All Time High | 13,900.0 |
| All Time Low | 1.16 |
| Ask | 5.21 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 29,910 |
| Average Daily Volume3 Month | 228,195 |
| Average Volume | 228,195 |
| Average Volume10Days | 29,910 |
| Beta | -0.538 |
| Bid | 1.66 |
| Bid Size | 2 |
| Book Value | 12.0 |
| City | Rehovot |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Israel |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.68 |
| Current Ratio | 3.696 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 1.8 |
| Day Low | 1.66 |
| Debt To Equity | 1.097 |
| Display Name | Purple Biotech |
| Dividend Date | 1,597,968,000 |
| Earnings Timestamp End | 1,755,523,740 |
| Earnings Timestamp Start | 1,755,178,140 |
| Ebitda | -7,840,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 0.536 |
| Enterprise Value | -4,204,363 |
| Eps Current Year | -5.73 |
| Eps Forward | -1.01 |
| Eps Trailing Twelve Months | -47.64 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 972 3 509 7196 |
| Fifty Day Average | 1.5518 |
| Fifty Day Average Change | 0.12819993 |
| Fifty Day Average Change Percent | 0.0826137 |
| Fifty Two Week Change Percent | -88.30986 |
| Fifty Two Week High | 19.4 |
| Fifty Two Week High Change | -17.72 |
| Fifty Two Week High Change Percent | -0.913402 |
| Fifty Two Week Low | 1.16 |
| Fifty Two Week Low Change | 0.52 |
| Fifty Two Week Low Change Percent | 0.44827586 |
| Fifty Two Week Range | 1.16 - 19.4 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,448,029,800,000 |
| Float Shares | 1,080,022 |
| Forward Eps | -1.01 |
| Forward P E | -1.6633663 |
| Free Cashflow | -4,903,375 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 10 |
| Fullday Change | 0.02 |
| Fullday Change Percent | 1.20482 |
| Fullday Price | 1.68 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Gross Profits | -59,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.037320003 |
| Held Percent Institutions | 0.070989996 |
| Implied Shares Outstanding | 1,626,867 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,772,409,600 |
| Last Split Factor | 1:10 |
| Long Business Summary | Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that blocks the interactions of carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 2 clinical trial for the treatment of pancreatic ductal adenocarcinoma; NT219, a small molecule that targets and inhibits insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 2 clinical trials for the treatment recurrent and/or metastatic squamous cell carcinoma of the head and neck cancer or colorectal adenocarcinoma; and CAPTN-3 - IM1240 and IM1305, multi-valent antibody designed to activate anti-tumoral immune response against TAA positive tumors, which is in preclinical stage. The company has collaboration agreement with Bristol Myers Squibb Company to evaluate the combination of CM24 with the PD-1 inhibitor nivolumab in addition to chemotherapy. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. The company was incorporated in 1968 and is headquartered in Rehovot, Israel. |
| Long Name | Purple Biotech Ltd |
| Market | us_market |
| Market Cap | 2,733,136 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_20357677 |
| Most Recent Quarter | 1,782,777,600 |
| Name Change Date | 2,026-08-28 |
| Net Income To Common | -24,493,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 10,917,654 |
| Number Of Analyst Opinions | 1 |
| Open | 1.7899 |
| Operating Cashflow | -7,758,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 972 3 933 3121 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 1.68 |
| Post Market Time | 1,787,959,805 |
| Prev Name | Kitov Pharma Ltd |
| Previous Close | 1.66 |
| Price Eps Current Year | -0.2931937 |
| Price Hint | 4 |
| Price To Book | 0.14 |
| Profit Margins | 0.0 |
| Quick Ratio | 3.424 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.02 |
| Regular Market Change Percent | 1.20482 |
| Regular Market Day High | 1.8 |
| Regular Market Day Low | 1.66 |
| Regular Market Day Range | 1.66 - 1.8 |
| Regular Market Open | 1.7899 |
| Regular Market Previous Close | 1.66 |
| Regular Market Price | 1.68 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 38,181 |
| Return On Assets | -0.20306 |
| Return On Equity | -1.11134 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 1,626,867 |
| Shares Percent Shares Out | 0.0161 |
| Shares Short | 26,155 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 18,265 |
| Short Name | Purple Biotech Ltd. |
| Short Percent Of Float | 0.0161 |
| Short Ratio | 0.39 |
| Source Interval | 15 |
| Symbol | PPBT |
| Target High Price | 17.0 |
| Target Low Price | 17.0 |
| Target Mean Price | 17.0 |
| Target Median Price | 17.0 |
| Total Cash | 6,105,000 |
| Total Cash Per Share | 5.621 |
| Total Debt | 134,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -47.64 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 4.38467 |
| Two Hundred Day Average Change | -2.70467 |
| Two Hundred Day Average Change Percent | -0.6168469 |
| Type Disp | Equity |
| Volume | 38,181 |
| Website | https://purple-biotech.com |
| Zip | 7,670,104 |